These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21179390)

  • 1. Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer.
    Burger AM; Kona F; Amemiya Y; Gao Y; Bacopulos S; Seth AK
    Open Cancer J; 2010; 3(1):116-123. PubMed ID: 21179390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
    Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK
    Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
    Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
    Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration.
    Amemiya Y; Azmi P; Seth A
    Mol Cancer Res; 2008 Sep; 6(9):1385-96. PubMed ID: 18819927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of partner proteins on BCA2 RING ligase activity.
    Bacopulos S; Amemiya Y; Yang W; Zubovits J; Burger A; Yaffe M; Seth AK
    BMC Cancer; 2012 Feb; 12():63. PubMed ID: 22315970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.
    Wang Z; Nie Z; Chen W; Zhou Z; Kong Q; Seth AK; Liu R; Chen C
    Neoplasia; 2013 Sep; 15(9):1028-35. PubMed ID: 24027428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the SUMO Ligase BCA2 on Metabolic Activity, Cell Proliferation, Cell Migration, Cell Cycle, and the Regulation of NF-κB and IRF1 in Different Breast Epithelial Cellular Contexts.
    Shi Y; Castro-Gonzalez S; Chen Y; Serra-Moreno R
    Front Cell Dev Biol; 2021; 9():711481. PubMed ID: 34589482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoubiquitination of feline E3 ubiquitin ligase BCA2.
    Wang W; Qu M; Wang J; Zhang X; Zhang H; Wu J; Yu B; Wu H; Kong W; Yu X
    Gene; 2018 Jan; 638():1-6. PubMed ID: 28964893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion and diversification of BTL ring-H2 ubiquitin ligases in angiosperms: putative Rabring7/BCA2 orthologs.
    Aguilar-Hernández V; Medina J; Aguilar-Henonin L; Guzmán P
    PLoS One; 2013; 8(8):e72729. PubMed ID: 23951330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy.
    Zhang R; Liu W; Sun J; Kong Y; Chen C
    Pharmacol Res; 2020 May; 155():104748. PubMed ID: 32147403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.
    Sohn SY; Hearing P
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.
    Brahemi G; Kona FR; Fiasella A; Buac D; Soukupová J; Brancale A; Burger AM; Westwell AD
    J Med Chem; 2010 Apr; 53(7):2757-65. PubMed ID: 20222671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel RING E3 ubiquitin ligases in breast cancer.
    Burger A; Amemiya Y; Kitching R; Seth AK
    Neoplasia; 2006 Aug; 8(8):689-95. PubMed ID: 16925951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
    Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
    Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCA2/Rabring7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IκBα.
    Colomer-Lluch M; Serra-Moreno R
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylated SnoN represses transcription in a promoter-specific manner.
    Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
    J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases.
    Wang MX; Liuyu T; Zhang ZD
    Front Immunol; 2022; 13():936579. PubMed ID: 35844553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of DNA Damage Response by Estrogen Receptor β-Mediated Inhibition of Breast Cancer Associated Gene 2.
    Lee YH; Sun Y; Gerweck LE; Glickman RD
    Biomedicines; 2015 Apr; 3(2):182-200. PubMed ID: 28536406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.